Gain- and loss-of-function experiments were performed next and showed that RBM5-AS1 is crucial for the proliferative, stemness maintenance, migratory and invasive capacities of breast cancer cells in vitro, and tumorigenicity of breast cancer cells in vivo. This evidence concerns the gene RBM5 and breast carcinoma.